Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35108705http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35108705http://www.w3.org/2000/01/rdf-schema#comment"

Introduction

The accumulation of lipofuscin is a hallmark in the pathogenesis of Stargardt disease type 1 (STGD1) and geographic atrophy (GA) secondary to age-related macular degeneration. Limiting lipofuscin accumulation by inhibiting the retinol-binding protein 4 (RBP4) is being explored as a potential treatment target for those diseases. In this study, we aimed to establish the concentration of RBP4 in the systemic circulation in different age cohorts of healthy individuals and to check if patients with STGD1 or GA may show abnormal RBP4 levels.

Methods

Forty healthy subjects of various age-groups, 15 Stargardt patients, and 15 GA patients were included in the study. We measured RBP4 levels, serum retinol (SR) levels, complete blood count, and blood chemistry including liver function tests.

Results

Mean RBP4 for all cohorts was 26,911.40 ± 6,198.61 ng/mL, and mean SR 1.75 ± 0.36 µmol/L. Age was not found to significantly impact levels neither of RBP4 and SR nor of the RBP4-to-SR ratio. Also, the 2 patient groups showed similar blood levels to their age-matched controls.

Conclusion

Serum RBP4 and SR do not appear to be affected by age in healthy individuals and remain within normal limits in both STGD1 and GA."xsd:string
http://purl.uniprot.org/citations/35108705http://purl.org/dc/terms/identifier"doi:10.1159/000522365"xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/author"Scholl H.P.N."xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/author"Cattaneo M."xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/author"Janeschitz-Kriegl L."xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/name"Ophthalmic Res"xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/pages"351-360"xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/title"Baseline Levels of Retinol-Binding Protein 4 and Vitamin A in Healthy Subjects, Stargardt Disease, and Geographic Atrophy Patients."xsd:string
http://purl.uniprot.org/citations/35108705http://purl.uniprot.org/core/volume"65"xsd:string
http://purl.uniprot.org/citations/35108705http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/35108705
http://purl.uniprot.org/citations/35108705http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/35108705
http://purl.uniprot.org/uniprot/#_P02753-mappedCitation-35108705http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35108705
http://purl.uniprot.org/uniprot/#_Q5VY30-mappedCitation-35108705http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35108705
http://purl.uniprot.org/uniprot/Q5VY30http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/35108705
http://purl.uniprot.org/uniprot/P02753http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/35108705